Krystal Biotech (KRYS) Work In Process (2023 - 2026)

Krystal Biotech has disclosed Work In Process across 4 years of filings, most recently posting $15.1 million for Q1 2026.

• Work In Process for Q1 2026 came in at $15.1 million, up 69.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.1 million (up 69.74% YoY), and the FY2025 annual result was $15.2 million, up 41.71% from the prior year.
• Work In Process came in at $15.1 million for Q1 2026 at Krystal Biotech, down from $15.2 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $15.8 million in Q3 2025 to a low of $3.2 million in Q4 2023.
• The 4-year median for Work In Process is $9.8 million (2024), against an average of $10.2 million.
• Across the five-year window, Work In Process surged 235.3% in 2024 and jumped 39.42% in 2025, its largest moves.
• Krystal Biotech's Work In Process stood at $3.2 million in 2023, then soared by 235.3% to $10.7 million in 2024, then jumped by 41.71% to $15.2 million in 2025, then declined by 0.72% to $15.1 million in 2026.
• The last three Work In Process figures came in at $15.1 million (Q1 2026), $15.2 million (Q4 2025), and $15.8 million (Q3 2025), per Business Quant data.